MGSSHHHHHH SSGLVPRGSH MDAVAVYHGK ISRETGEKLL LATGLDGSYL LRDSESVPGV YCLCVLYHGY IYTYRVSQTE TGSWSAETAP GVHKRYFRKI KNLISAFQKP DQGIVIPLQY PVEKKSSARS TQGTTGIRED PDVCLKAP.
SH2 domain containing 1A (SH2D1A), also known as Signaling Lymphocytic Activation Molecule-Associated Protein (SLAM-associated protein or SAP), is a protein encoded by the SH2D1A gene in humans. This protein plays a crucial role in the immune system, particularly in the signaling pathways of T and B cells .
The SH2D1A protein contains an SH2 (Src Homology 2) domain, which is a structurally conserved protein domain found in many intracellular signal-transducing proteins . The SH2 domain allows the protein to bind to phosphorylated tyrosine residues on other proteins, thereby modifying the function or activity of the SH2-containing protein . This binding is essential for the transmission of signals that control various cellular functions.
SH2D1A is primarily involved in the bidirectional stimulation of T and B cells. It associates with the signaling lymphocyte-activation molecule (SLAM), acting as an inhibitor by blocking the recruitment of the SH2-domain-containing signal-transduction molecule SHP-2 to its docking site . Additionally, SH2D1A can bind to other related surface molecules expressed on activated T, B, and NK cells, thereby modifying signal transduction pathways in these cells .
Mutations in the SH2D1A gene are associated with lymphoproliferative syndrome X-linked type 1 (XLP1), also known as Duncan disease . This rare immunodeficiency disorder is characterized by extreme susceptibility to infection with the Epstein-Barr virus (EBV), leading to severe mononucleosis and malignant lymphoma . Multiple transcript variants encoding different isoforms of SH2D1A have been identified, highlighting the complexity of its regulation and function .
The recombinant form of SH2D1A is used in various research applications to study its role in immune signaling pathways and its involvement in diseases. Understanding the function and regulation of SH2D1A can provide insights into potential therapeutic targets for treating immune-related disorders.